Skip to main content
. 2023 Jan 1;17(1):4–8. doi: 10.18502/ijhoscr.v17i1.11707

Table 3.

Frequency of alloantibodies compared to age and sex parameters

Age Number
of
patients
Number of
patients with
alloantibodies
Anti-D Anti-C Anti-E Anti-K Anti-JK a Anti-Fy a
10 92 1
(2.9%)
0 0 0 1
(2.9%)
0 0
11-19 130 14
(41.2%)
3
(8.8%)
2
(5.8%)
3
(8.8%)
6
(17.6%)
0 0
20-28 134 11
(32.4%)
4
(11.7%)
2
(5.8%)
0 3
(8.8%)
0 1
(2.9%)
29-38 71 6
(17.6%)
1
(2.9%)
0 2
(5.8%)
3
(8.8%)
1
(2.9%)
0
39-47 11 0 0 0 0 0 0 0
48-56 6 1
(2.9%)
0 0 0 0 0 0
57+ 2 1
(2.9%)
0 1
(2.9%)
0 0 0 0
Total 446 34 8
(23.5%)
5
(14.7%)
5
(14.7%)
13
(38.2%)
1
(2.9%)
1
(2.9%)
Gender
Male 249 14
(3.1%)
2
(14.2%)
2
(14.2%)
3
(21.4%)
7
(50%)
0 0
Female 197 20
(4.4%)
6
(30%)
3
(15%)
2
(10%)
6
(30%)
1
(5%)
1
(5%)